Texas Yale Capital Corp’s iShares Biotechnology ETF IBB Stock Holding History

Texas Yale Capital Corp’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.44M	Hold	12,840	–	–	0.05%	193
2026 Q1	$2.17M	Hold	12,840	–	–	0.06%	192
2025 Q4	$2.17M	Hold	12,840	–	–	0.07%	188
2025 Q3	$1.85M	Hold	12,840	–	–	0.06%	202
2025 Q2	$1.62M	Sell	12,840 -3,192	-20%	-$392K	0.05%	210
2025 Q1	$2.05M	Hold	16,032	–	–	0.08%	183
2024 Q4	$2.12M	Sell	16,032 -415	-3%	-$58.3K	0.09%	181
2024 Q3	$2.39M	Buy	16,447 +3,192	+24%	+$462K	0.1%	166
2024 Q2	$1.82M	Hold	13,255	–	–	0.09%	184
2024 Q1	$1.82M	Hold	13,255	–	–	0.08%	188
2023 Q4	$1.8M	Hold	13,255	–	–	0.09%	180
2023 Q3	$1.62M	Hold	13,255	–	–	0.07%	182
2023 Q2	$1.68M	Hold	13,255	–	–	0.08%	186
2023 Q1	$1.71M	Hold	13,255	–	–	0.09%	187
2022 Q4	$1.74M	Hold	13,255	–	–	0.1%	175
2022 Q3	$1.55M	Hold	13,255	–	–	0.1%	180
2022 Q2	$1.56M	Buy	13,255 +10,182	+331%	+$1.21M	0.1%	178
2022 Q1	$400K	Sell	3,073 -117	-4%	-$15.2K	0.02%	344
2021 Q4	$487K	Buy	3,190 +365	+13%	+$56.5K	0.02%	327
2021 Q3	$457K	Hold	2,825	–	–	0.03%	329
2021 Q2	$462K	Hold	2,825	–	–	0.03%	325
2021 Q1	$425K	Sell	2,825 -50	-2%	-$7.94K	0.03%	329
2020 Q4	$436K	Hold	2,875	–	–	0.03%	323
2020 Q3	$389K	Sell	2,875 -3	-0.1%	-$407	0.03%	320
2020 Q2	$393K	Sell	2,878 -12	-0.4%	-$1.53K	0.03%	318
2020 Q1	$311K	Sell	2,890 -588	-17%	-$67.7K	0.03%	321
2019 Q4	$419K	Hold	3,478	–	–	0.03%	347
2019 Q3	$346K	Hold	3,478	–	–	0.02%	366
2019 Q2	$379K	Sell	3,478 -3,478	-50%	-$370K	0.03%	363
2019 Q1	$778K	Buy	6,956 +3,478	+100%	+$381K	0.03%	349
2018 Q4	$335K	Buy	3,478 +700	+25%	+$74.3K	0.03%	351
2018 Q3	$339K	Hold	2,778	–	–	0.03%	372
2018 Q2	$305K	Hold	2,778	–	–	0.03%	381
2018 Q1	$297K	Hold	2,778	–	–	0.03%	393
2017 Q4	$297K	Hold	2,778	–	–	0.03%	400
2017 Q3	$309K	Sell	2,778 -54	-2%	-$5.77K	0.03%	382
2017 Q2	$293K	Buy	2,832 +54	+2%	+$5.32K	0.03%	387
2017 Q1	$272K	Hold	2,778	–	–	0.02%	396
2016 Q4	$246K	Hold	2,778	–	–	0.02%	395
2016 Q3	$268K	Hold	2,778	–	–	0.03%	394
2016 Q2	$238K	Hold	2,778	–	–	0.02%	411
2016 Q1	$242K	Hold	2,778	–	–	0.02%	398
2015 Q4	$313K	Hold	2,778	–	–	0.03%	362
2015 Q3	$281K	Hold	2,778	–	–	0.03%	395
2015 Q2	$342K	Hold	2,778	–	–	0.03%	395
2015 Q1	$318K	Hold	2,778	–	–	0.03%	407
2014 Q4	$281K	Hold	2,778	–	–	0.02%	404
2014 Q3	$253K	Hold	2,778	–	–	0.02%	388
2014 Q2	$238K	Sell	2,778 -15	-0.5%	-$1.18K	0.03%	336
2014 Q1	$220K	Buy	+2,793	New	+$233K	0.03%	335

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Texas Yale Capital Corp's IBB Position: Q2 2026 in Review

Texas Yale Capital Corp held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 12,840 shares worth $2.44M. The position accounts for 0.05% of the portfolio, ranked #193.

Texas Yale Capital Corp first reported a position in IBB in Q1 2014 and has held it in 50 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Texas Yale Capital Corp held 12,840 shares of iShares Biotechnology ETF worth $2.44M as of Q2 2026.
Texas Yale Capital Corp left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.05% of Texas Yale Capital Corp's portfolio in Q2 2026, its #193 holding.
Texas Yale Capital Corp first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 50 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.